公开(公告)号：WO9631186A3

公开(公告)日：1996-11-14

申请号：PCT/US9601790

申请日：1996-02-08

Applicant: ABBOTT LAB

Inventor： HILTY MILO DUANE ,  ANDERSON STEVEN NEAL ,  SCHALLER JOSEPH PAUL ,  LIU JIN-ZHOU

IPC: A61K39/395 ,  A61K35/20 ,  A61P11/00 ,  A61P31/12 ,  A61P31/14 ,  A61P31/16 ,  A61P31/20 ,  C07K16/10 ,  A61K

CPC classification number: C07K16/1027

Abstract: A method of treating pneumonia or other respiratory disease caused by respiratory syncytial virus, adenovirus, parainfluenza virus, or influenza virus by orally administering a liquid, preferably an infant formula, containing a virus neutralizing antibody.

公开(公告)号：WO9702829A3

公开(公告)日：1997-03-27

申请号：PCT/US9611201

申请日：1996-07-02

Applicant: ABBOTT LAB

Inventor： DOHNALEK MARGARET IONE HALPIN ,  OSTROM KARIN MARGARET ,  HILTY MILO DUANE

IPC: A61K31/702 ,  A23C9/13 ,  A23G3/34 ,  A23L2/52 ,  A23L29/244 ,  A61K31/715 ,  A61K31/733 ,  A61P1/12 ,  A61K31/70

CPC classification number: A61K31/715 ,  A23C9/1307 ,  A23G3/346 ,  A23G2200/06 ,  A23L2/52 ,  A23L29/244 ,  A61K31/702 ,  A61K31/733 ,  Y10S514/867

Abstract: A method is provided for reducing the duration of diarrhea and recurrent episodes of diarrhea in humans by enterally administering indigestible oligosaccharides prophylactically. More specifically, the present invention relates to a method using indigestible oligosaccharides or fructooligosaccharides (FOS) to reduce the duration and recurrence of diarrhea in a human wherein between 0.5 grams and 5 grams of at least one FOS selected from the group consisting of 1-kestose, nystose, and 1F- beta -fructofuranosyl nystose is administered to said human per day. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gum, lozenges, milk, yogurts, fermented products and the like.

Abstract translation: 提供一种通过预防肠内施用难消化的寡糖来减少人体腹泻和腹泻复发的持续时间的方法。 更具体地，本发明涉及使用难消化的寡糖或低聚果糖（FOS）来减少人的腹泻持续时间和复发的方法，其中0.5克和5克之间的至少一种FOS选自1-睾丸 ，蔗糖，和1F-β-呋喃果糖基糖苷每天施用于所述人。 不可消化的寡糖可以通过酶合成，化学技术或从植物材料中分离而产生，并以营养产品，糖果，片剂，口香糖，锭剂，牛奶，酸奶，发酵产品等的形式施用。

公开(公告)号：WO9702830A3

公开(公告)日：1997-04-10

申请号：PCT/US9611243

申请日：1996-07-02

Applicant: ABBOTT LAB

Inventor： DOHNALEK MARGARET IONE HALPIN ,  OSTROM KARIN MARGARET ,  HILTY MILO DUANE

IPC: A23C9/152 ,  A23C9/20 ,  A23G3/00 ,  A23G3/36 ,  A23L1/30 ,  A23L1/308 ,  A23L2/52 ,  A61K31/702 ,  A61P27/16 ,  A61P43/00 ,  A61K31/70 ,  A61K31/715

CPC classification number: A23G3/368 ,  A23C9/203 ,  A23L2/52 ,  A23L33/10 ,  A23L33/21 ,  A23V2002/00 ,  A61K31/702 ,  A23V2250/28 ,  A23V2250/70 ,  A23V2250/156

Abstract: A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible fructooligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible fructooligosaccharide selected from the group consisting of 1-kestose, nystose and 1-F-B-fructofuranosyl nystose . The indigestible fructooligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the fructooligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides FG2, GF3, and GF4.